Katz Barrett
Insider CIK 1841628 · VRDN Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2023-02-08 | 2023-02-10 | 108,000 | — | $0 | 108,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2023-01-17 | 2023-01-18 | 24,853 | — | $0 | 267,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-01-17 | 2023-01-18 | 24,853 | $37.21 | $924.8K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2023-01-17 | 2023-01-18 | 24,853 | $23.03 | $572.4K | 24,853 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2023-01-13 | 2023-01-18 | 4,147 | — | $0 | 291,853 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-01-13 | 2023-01-18 | 4,147 | $37.01 | $153.5K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2023-01-13 | 2023-01-18 | 4,147 | $23.03 | $95.5K | 4,147 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2023-01-10 | 2023-01-11 | 47,377 | — | $0 | 296,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-01-10 | 2023-01-11 | 47,377 | $35.30 | $1.67M | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2023-01-10 | 2023-01-11 | 47,377 | $23.03 | $1.09M | 47,377 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2023-01-09 | 2023-01-11 | 12,623 | — | $0 | 343,377 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-01-09 | 2023-01-11 | 12,623 | $33.04 | $417.1K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2023-01-09 | 2023-01-11 | 12,623 | $23.03 | $290.7K | 12,623 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2022-02-02 | 2022-02-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2021-01-18 | 2021-01-21 | 356,000 | — | $0 | 356,000 | SEC↗ |